{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:51:44Z","timestamp":1783525904546,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Autonomic Research"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/bf02329922","type":"journal-article","created":{"date-parts":[[2006,3,14]],"date-time":"2006-03-14T17:16:03Z","timestamp":1142356563000},"page":"145-154","source":"Crossref","is-referenced-by-count":49,"title":["Autonomic dysfunction in Lambert-Eaton myasthenic syndrome"],"prefix":"10.1007","volume":"11","author":[{"given":"Sally A.","family":"Waterman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02329922_CR1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","volume":"111","author":"JH O'Neill","year":"1988","unstructured":"O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases.Brain 1988; 111:577\u2013596.","journal-title":"Brain"},{"key":"BF02329922_CR2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM198912073212303","volume":"321","author":"KM McEvoy","year":"1989","unstructured":"McEvoy KM, Windebank AJ, Daube JR,et al. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome.N Engl J Med 1989; 321:1567\u20131571.","journal-title":"N Engl J Med"},{"key":"BF02329922_CR3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.50.1.88","volume":"50","author":"P O'Suilleabhain","year":"1998","unstructured":"O'Suilleabhain, P, Low, PA, Lennon, VA. Autonomic dysfunction in the Lambert-Eaton-myasthenic-syndrome\u2014serologic and clinical correlates.Neurology 1998; 50:88\u201393.","journal-title":"Neurology"},{"key":"BF02329922_CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0090-4295(98)00583-4","volume":"54","author":"DR Collins","year":"1999","unstructured":"Collins DR, Connolly S, Burns M,et al. Lambert-Eaton myasthenic syndrome in association with transitional cell carcinoma: a previously unrecognised association.Urology (Online) 1999; 54:162.","journal-title":"Urology (Online)"},{"key":"BF02329922_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00194096","volume":"17","author":"B Lang","year":"1995","unstructured":"Lang, B, Newsom-Davis, J. Immunopathology of the Lambert-Eaton myasthenic syndrome.Springer Semin Immunopathol 1995; 17:3\u201315.","journal-title":"Springer Semin Immunopathol"},{"key":"BF02329922_CR6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.1983.sp014943","volume":"344","author":"B Lang","year":"1983","unstructured":"Lang B, Newsom-Davis J, Prior C,et al. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.J Physiol 1983; 344:335\u2013345.","journal-title":"J Physiol"},{"key":"BF02329922_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.410170610","volume":"17","author":"C Prior","year":"1985","unstructured":"Prior C, Lang B, Wray D,et al. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.Ann Neurol 1985; 17:587\u2013592.","journal-title":"Ann Neurol"},{"key":"BF02329922_CR8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1113\/jphysiol.1987.sp016698","volume":"390","author":"B Lang","year":"1987","unstructured":"Lang B, Newsom-Davis J, Peers C,et al. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.J Physiol 1987; 390:257\u2013270.","journal-title":"J Physiol"},{"key":"BF02329922_CR9","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1073\/pnas.80.24.7636","volume":"80","author":"H Fukunaga","year":"1983","unstructured":"Fukunaga H, Engel AG, Lang B,et al. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.Proc Natl Acad Sci USA 1983; 80:7636\u20137640.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02329922_CR10","first-page":"123","volume":"20","author":"H Fukuoka","year":"1986","unstructured":"Fukuoka H, Engel AG, Lang B,et al. Immunolocalization of Lambert-Eaton myasthenic syndrome IgG to the presynaptic membrane active zone.Ann Neurol 1986; 20:123.","journal-title":"Ann Neurol"},{"key":"BF02329922_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410220204","volume":"22","author":"T Fukuoka","year":"1987","unstructured":"Fukuoka T, Engel AG, Lang B,et al. Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate.Ann Neurol 1987; 22:200\u2013211.","journal-title":"Ann Neurol"},{"key":"BF02329922_CR12","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","volume":"332","author":"VA Lennon","year":"1995","unstructured":"Lennon VA, Kryzer TJ, Griesmann GE,et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.E Engl J Med 1995; 332:1467\u20131474.","journal-title":"E Engl J Med"},{"key":"BF02329922_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.58.1.85","volume":"58","author":"M Motomura","year":"1995","unstructured":"Motomura M, Johnston I, Lang B,et al. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.J Neurol Neurosurg Psychiatr 1995; 58:85\u201387.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"BF02329922_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","volume":"147","author":"M Motomura","year":"1997","unstructured":"Motomura M, Lang B, Johnston I,et al. Incidence of serum anti-P\/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.J Neurol Sci 1997; 147:35\u201342.","journal-title":"J Neurol Sci"},{"key":"BF02329922_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3940(93)90073-T","volume":"153","author":"C Peers","year":"1993","unstructured":"Peers C, Johnston I, Lang B,et al. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.Neurosci Lett 1993; 153:45\u201348.","journal-title":"Neurosci Lett"},{"key":"BF02329922_CR16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(95)11350-9","volume":"187","author":"N Martin-Moutot","year":"1995","unstructured":"Martin-Moutot N, Lang B, Newsom-Davis J,et al. Binding of Lambert-Eaton myasthenic syndrome IgG to synaptosomal proteins does not correlate with an inhibition of calcium uptake.Neurosci Lett 1995; 187:115\u2013118.","journal-title":"Neurosci Lett"},{"key":"BF02329922_CR17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp.51.3.436","volume":"51","author":"JP Heath","year":"1988","unstructured":"Heath, JP, Ewing, DJ, Cull, RE. Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome.J Neurol Neurosurg Psychiatr 1988; 51:436\u2013439.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"BF02329922_CR18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1212\/WNL.50.2.470","volume":"50","author":"JS Katz","year":"1988","unstructured":"Katz JS, Wolffe GI, Bryan WW,et al. Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome.Neurology 1988; 50:470\u2013475.","journal-title":"Neurology"},{"key":"BF02329922_CR19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410110604","volume":"11","author":"PC Dau","year":"1982","unstructured":"Dau PC, Denys EH. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome.Ann Neurol 1982; 11:570\u2013575.","journal-title":"Ann Neurol"},{"key":"BF02329922_CR20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/WNL.34.10.1324","volume":"34","author":"H Lundh","year":"1984","unstructured":"Lundh H, Nilsson O, Rosen I. Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine.Neurology 1984; 34:1324\u20131330.","journal-title":"Neurology"},{"key":"BF02329922_CR21","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1212\/WNL.29.5.720","volume":"29","author":"AE Rubenstein","year":"1979","unstructured":"Rubenstein AE, Horwitz SH, Bender AN. Cholinergic dysautonomia and Eaton-Lambert syndrome.Neurology 1979; 29:720\u2013723.","journal-title":"Neurology"},{"key":"BF02329922_CR22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/eye.1990.61","volume":"4","author":"CV Clark","year":"1990","unstructured":"Clark CV, Newsom-Davis J, Sanders MD. Ocular autonomic nerve function in Lambert-Eaton myasthenic syndrome.Eye 1990; 4:473\u2013481.","journal-title":"Eye"},{"key":"BF02329922_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-510X(88)90037-8","volume":"85","author":"RK Khurana","year":"1988","unstructured":"Khurana RK, Koski CL, Mayer RF. Autonomic dysfunction in Lambert-Eaton myasthenic synndrome.J Neurol Sci 1988; 85:77\u201386.","journal-title":"J Neurol Sci"},{"key":"BF02329922_CR24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archneur.1986.00520090079023","volume":"43","author":"MA Tabbaa","year":"1986","unstructured":"Tabbaa MA, Leshner RT, Campbell WW. Malignant thymoma with dysautonomia and disordered neuromuscular transmission.Arch Neurol 1986; 43:955\u2013957.","journal-title":"Arch Neurol"},{"key":"BF02329922_CR25","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0025-6196(12)65705-X","volume":"64","author":"VA Lennon","year":"1989","unstructured":"Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome.Mayo Clin Proc 1989; 64:1498\u20131504.","journal-title":"Mayo Clin Proc"},{"key":"BF02329922_CR26","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(89)91129-X","volume":"2","author":"K Leys","year":"1989","unstructured":"Leys K, Lang B, Vincent A,et al. Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome [letter].Lancet 1989; 2:1107.","journal-title":"Lancet"},{"key":"BF02329922_CR27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(89)90893-3","volume":"2","author":"E Sher","year":"1989","unstructured":"Sher E, Gotti C, Canal N,et al. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.Lancet 1989; 2:640\u2013643.","journal-title":"Lancet"},{"key":"BF02329922_CR28","first-page":"3892","volume":"50","author":"E Sher","year":"1990","unstructured":"Sher E, Pandiella A, Clementi F. Voltage-operated calcium channels in small cell lung carcinoma cell lines: pharmacological, functional, and immunological properties.Cancer Res 1990; 50:3892\u20133896.","journal-title":"Cancer Res"},{"key":"BF02329922_CR29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.410290313","volume":"29","author":"K Leys","year":"1991","unstructured":"Leys K, Lang B, Johnston, I,et al. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.Ann Neurol 1991; 29:307\u2013314.","journal-title":"Ann Neurol"},{"key":"BF02329922_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0301-0082(99)00025-8","volume":"60","author":"SA Waterman","year":"2000","unstructured":"Waterman, SA. Voltage-gated calcium channels in autonomic neuroeffector transmission.Prog Neurobiol 2000; 60:181\u2013210.","journal-title":"Prog Neurobiol"},{"key":"BF02329922_CR31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S,et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.Nature Med 2001; 7:365\u2013368.","journal-title":"Nature Med"},{"key":"BF02329922_CR32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jnnp.54.5.452","volume":"54","author":"J Newsom-Davis","year":"1991","unstructured":"Newsom-Davis J, Leys K, Vincent A,et al. Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients.J Neurol Neurosurg Psychiatr 1991; 54:452\u2013453.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"BF02329922_CR33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.50.3.652","volume":"50","author":"CF Lucchinetti","year":"1998","unstructured":"Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.Neurology 1998; 50:652\u2013657.","journal-title":"Neurology"},{"key":"BF02329922_CR34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-0404.1977.tb01417.x","volume":"56","author":"KG Henriksson","year":"1977","unstructured":"Henriksson KG, Nilsson O, Rosen I,et al. Clinical, neurophysiological and morphological findings in Eaton Lambert syndrome.Acta Neurol Scand 1977; 56: 117\u2013140.","journal-title":"Acta Neurol Scand"},{"key":"BF02329922_CR35","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.54.11.2176","volume":"54","author":"RW Tim","year":"2000","unstructured":"Tim RW, Massey JM, Sanders DB. Lambert-Eaton myasthenic syndrome; electrodiagnostic findings and response to treatment.Neurology 2000; 54:2176\u20132178.","journal-title":"Neurology"},{"key":"BF02329922_CR36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF02048484","volume":"18","author":"M Riva","year":"1997","unstructured":"Riva M, Brioschi AM, Marazzi R,et al. Immunological and endocrinological abnormalities in paraneoplastic disorders with involvement of the autonomic nervous system.Ital J Neurol Sci 1997; 18:157\u2013161.","journal-title":"Ital J Neurol Sci"},{"key":"BF02329922_CR37","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","volume":"50","author":"S Vernino","year":"1998","unstructured":"Vernino S, Adamski J, Kryzer TJ,et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancerelated syndromes.Neurology 1998; 50:1806\u20131813.","journal-title":"Neurology"},{"key":"BF02329922_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-5728(99)00145-9","volume":"102","author":"B Balestra","year":"2000","unstructured":"Balestra B, Moretti M, Longhi R,et al. Antibodies against neuronal nicotinic receptor subtypes in neurological disorders.J Neuroimmunol 2000; 102:89\u201397.","journal-title":"J Neuroimmunol"},{"key":"BF02329922_CR39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410430520","volume":"43","author":"H Houzen","year":"1988","unstructured":"Houzen H, Hattori Y, Kanno M,et al. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.Ann Neurol 1988; 43:677\u2013680.","journal-title":"Ann Neurol"},{"key":"BF02329922_CR40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410420204","volume":"42","author":"SA Waterman","year":"1997","unstructured":"Waterman SA, Lang B, Newsom-Davis J. Effect of Lambert-Eaton myasthenic syndrome antibodies on transmitter release from autonomic neurons in the mouse.Ann Neurol 1997; 42:147\u2013156.","journal-title":"Ann Neurol"},{"key":"BF02329922_CR41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0306-4522(99)00505-9","volume":"95","author":"AB Smith","year":"2000","unstructured":"Smith AB, Motin L, Lavidis NA,et al. Calcium channels controlling acetylcholine release from preganglionic nerve terminals in rat autonomic ganglia.Neuroscience 2000; 95:1121\u20131127.","journal-title":"Neuroscience"},{"key":"BF02329922_CR42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0306-4522(99)00286-9","volume":"94","author":"AB Smith","year":"1999","unstructured":"Smith AB, Cunnane TC. Calcium channels controlling acetylcholine release in the guinea-pig isolated anterior pelvic ganglion: an electropharmacological study.Neuroscience 1999; 94:891\u2013896.","journal-title":"Neuroscience"},{"key":"BF02329922_CR43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0306-4522(94)00368-F","volume":"64","author":"GR Gonzales-Burgos","year":"1995","unstructured":"Gonzales-Burgos GR, Biali FI, Cherksey BD,et al. Different calcium channels mediate transmitter release evoked by transient or sustained depolarization at mammalian sympathetic ganglia.Neuroscience 1995; 64:117\u2013123.","journal-title":"Neuroscience"},{"key":"BF02329922_CR44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1469-7793.1999.059af.x","volume":"514","author":"DR Ireland","year":"1999","unstructured":"Ireland DR, Davies PJ, McLachlan EM. Calcium channel subtypes differ at two types of cholinergic synapse in lumbar sympathetic neurones of guinea-pig.J Physiol 1999; 514:59\u201369.","journal-title":"J Physiol"},{"key":"BF02329922_CR45","first-page":"162","volume":"11","author":"K Nichols","year":"2000","unstructured":"Nichols K, Duffield M, Beattie R,et al. Differential expression patterns of voltage-gated calcium channel subunits in enteric neurons of the mouse colon [abstract].Proc Aust Neurosci Soc 2000; 11:162.","journal-title":"Proc Aust Neurosci Soc"},{"key":"BF02329922_CR46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1523\/JNEUROSCI.20-01-00163.2000","volume":"20","author":"J Qian","year":"2000","unstructured":"Qian J, Noebels JL. Presynaptic Ca2+ influx at a mouse central synapse with Ca2+ channel subunit mutations.J Neurosci 2000; 20:163\u2013170.","journal-title":"J Neurosci"},{"key":"BF02329922_CR47","first-page":"1","volume-title":"Autonomic neuroeffector mechanisms vol. 1","author":"G Gabella","year":"1992","unstructured":"Gabella, G. Fine structure of post-ganglionic nerve fibers and autonomic neuroeffector junctions. In:Autonomic neuroeffector mechanisms vol. 1. Bumstock G, Hoyle CHV, eds. Chur: Harwood Academic Publishers, 1992. pp. 1\u201331."},{"key":"BF02329922_CR48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1113\/jphysiol.1987.sp016698","volume":"390","author":"B Lang","year":"1987","unstructured":"Lang B, Newsom-Davis J, Peers C,et al. The action of myasthenic syndrome antibody fragments on transmitter release in the mouse.J Physiol 1987; 390:173P.","journal-title":"J Physiol"},{"key":"BF02329922_CR49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410220203","volume":"22","author":"T Fukuoka","year":"1987","unstructured":"Fukuoka T, Engel AG, Lang B,et al. Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones.Ann Neurol 1987; 22:193\u2013199.","journal-title":"Ann Neurol"},{"key":"BF02329922_CR50","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1523\/JNEUROSCI.12-09-03372.1992","volume":"12","author":"M Passafaro","year":"1992","unstructured":"Passafaro M, Clementi F, Sher E. Metabolism of omegaconotoxin-sensitive voltage-operated calcium channels in human eeuroblastoma cells: modulation by cell differentiation and antichannel antibodies.J Neurosci 1992; 12:3372\u20133379.","journal-title":"J Neurosci"},{"key":"BF02329922_CR51","first-page":"104","volume-title":"Neurotransmitter release and its modulation","author":"BB Fredholm","year":"1995","unstructured":"Fredholm BB. Modulation of neurotransmitter release by heteroreceptors. In:Neurotransmitter release and its modulation. Powse DA, Bunn SJ, eds. Cambridge: Cambridge University Press; 1995. pp. 104\u2013121."},{"key":"BF02329922_CR52","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/jnnp.54.9.764","volume":"54","author":"GM Elrington","year":"1991","unstructured":"Elrington GM, Murray NM, Spiro SG,et al. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients.J Neurol Neurosurg Psychiatr 1991; 54:764\u2013767.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"BF02329922_CR53","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.42.10.1944","volume":"42","author":"PD Clouston","year":"1992","unstructured":"Clouston PD, Saper CB, Arbizu T,et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome.Neurology 1992; 42:1944\u20131950.","journal-title":"Neurology"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02329922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02329922\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02329922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T18:05:16Z","timestamp":1558029916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02329922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["BF02329922"],"URL":"https:\/\/doi.org\/10.1007\/bf02329922","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}